Thrombocytopenia, Neonatal Alloimmune
"Thrombocytopenia, Neonatal Alloimmune" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition in newborns caused by immunity of the mother to PLATELET ALLOANTIGENS on the fetal platelets. The PLATELETS, coated with maternal ANTIBODIES, are destroyed and removed by the fetal MONONUCLEAR PHAGOCYTE SYSTEM. Affected infants may have INTRACRANIAL HEMORRHAGES.
MeSH Number(s)
C15.378.140.855.850
C16.614.899
Concept/Terms
Thrombocytopenia, Neonatal Alloimmune- Thrombocytopenia, Neonatal Alloimmune
- Alloimmune Thrombocytopenia, Neonatal
- Alloimmune Thrombocytopenias, Neonatal
- Neonatal Alloimmune Thrombocytopenias
- Thrombocytopenias, Neonatal Alloimmune
- Neonatal Thrombocytopenia
- Neonatal Thrombocytopenias
- Thrombocytopenia, Neonatal
- Thrombocytopenias, Neonatal
- Neonatal Alloimmune Thrombocytopenia
Below are MeSH descriptors whose meaning is more general than "Thrombocytopenia, Neonatal Alloimmune".
Below are MeSH descriptors whose meaning is more specific than "Thrombocytopenia, Neonatal Alloimmune".
This graph shows the total number of publications written about "Thrombocytopenia, Neonatal Alloimmune" by people in Harvard Catalyst Profiles by year, and whether "Thrombocytopenia, Neonatal Alloimmune" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 3 | 0 | 3 |
Below are the most recent publications written about "Thrombocytopenia, Neonatal Alloimmune" by people in Profiles.
-
Multidisciplinary management of a pregnancy complicated by Glanzmann thrombasthenia: A case report. Transfusion. 2023 12; 63(12):2384-2391.
-
Neonatal Thrombocytopenia: Factors Associated With the Platelet Count Increment Following Platelet Transfusion. J Pediatr. 2023 Dec; 263:113666.
-
HLA antibodies in fetal and neonatal alloimmune thrombocytopenia. Transfusion. 2023 06; 63(6):1141-1149.
-
Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study. Lancet Haematol. 2022 Nov; 9(11):e844-e853.
-
The immature platelet fraction: creating neonatal reference intervals and using these to categorize neonatal thrombocytopenias. J Perinatol. 2017 07; 37(7):834-838.
-
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia. Transfusion. 2016 Oct; 56(10):2449-2454.
-
Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol. 2016 Oct; 215(4):471.e1-9.
-
Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies. Blood. 2015 Sep 03; 126(10):1234-6.
-
A Doppler velocimetry evaluation of intestinal blood flow characteristics in neonates receiving intravenous immunoglobulin therapy: a prospective observational study. Indian J Pediatr. 2015 Jun; 82(6):553-7.
-
Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice. Transfusion. 2013 Nov; 53(11):2814-21; quiz 2813.